[en] The bla genes identification present in 94 phenotypically resistant Escherichia coli isolated from feces or intestinal contents of young calves with diarrhea or enteritis in Belgium was performed by microarrays (MA) and
whole genome sequencing (WGS). According to their resistance phenotypes to 8 b-lactams at the disk diffusion
assay these 94 E. coli produced a narrow-spectrum-b-lactamase (NSBL), an extended-spectrum-b-lactamase
(ESBL) or a cephalosporinase (AmpC). All ESBL-encoding genes identified by MA and WGS belonged to the
blaCTX-M family, with a majority to the blaCTX-M-1 subfamily. Two different genes encoding an AmpC, blaCMY-2,
and blaDHA-1 were detected in isolates with an AmpC phenotype. The blaTEM-1 and the blaOXA-1 were detected
alone in isolates with a NSBL phenotype or in combination with ESBL-/AmpC-encoding bla genes. Furthermore, the WGS identified mutations in the ampC gene promoter at nucleotides -42 (C>T) and/or -18 (G>A) that
could not be identified by MA, in several isolates with an AmpC-like resistance phenotype. No carbapenemaseencoding gene was detected. To our knowledge this is the first survey on the identification of bla genes in E. coli
isolated from young diarrheic or septicemic calves in Belgium.
Thiry, Damien ; Université de Liège - ULiège > Département des maladies infectieuses et parasitaires (DMI) > Bactériologie et pathologie des maladies bactériennes
Lucas, Perrick
Blanchard, Yannick
Cawez, Frédéric ; Université de Liège - ULiège > Département des sciences de la vie > Macromolécules biologiques
Mercuri, Paola ; Université de Liège - ULiège > Département des sciences de la vie > Macromolécules biologiques
Mainil, Jacques ; Université de Liège - ULiège > Département des maladies infectieuses et parasitaires (DMI) > Bactériologie et pathologie des maladies bactériennes
Language :
English
Title :
Identification of b-Lactamase-Encoding (bla) Genes in Phenotypically b-Lactam-Resistant Escherichia coli Isolated from Young Calves in Belgium
Publication date :
2021
Journal title :
Microbial Drug Resistance: Mechanism, Epidemiology, and Disease
ISSN :
1076-6294
eISSN :
1931-8448
Publisher :
Mary Ann Liebert, Larchmont, United States - New York
Organisation for Economic Co-operation and Development (OECD). 2018. Stemming the Superbug Tide: Just A Few Dollars More, OECD Health Policy Studies. OECD Publication, Paris.
Fleming, A. 1929. On the antibacterial action of cultures of a Penicillium, with special reference to their use in the isolation of B. influenzae. Br. J. Exp. Pathol. 10: 226-236.
Abraham, E.P., E. Chain. 1940. An enzyme from bacteria able to destroy penicillin. Nature 3713: 837.
Jacoby, G.A. 2009. AmpC B-lactamases. Clin. Microbiol. Rev. 22: 161-182.
Frère J.-M., E. Sauvage, and F. Kerff. 2016. From ''An enzyme able to destroy penicillin" to carbapenemases: 70 years of betalactamase misbehavior. Curr. Drug Targets 17: 974-982.
Burman, L., J. Park, B. Lindström, and H. Boman. 1973. Resistance of Escherichia coli to Penicillins: identification of the structural gene for the chromosomal penicillinase. J. Bacteriol. 116: 123-130.
Livermore, D. 1995. b-Lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8: 557-584.
Pham, J.N., I. Chambers, L. Poirel, P. Nordmann, and S.M. Bell. 2010. Detection of a plasmid-mediated inducible cephalosporinase DHA-1 from Escherichia coli. Pathology 42: 196-197.
Naas, T., S. Oueslati, R.A. Bonnin, et al. 2017. Betalactamase database (BLDB)-structure and function. J. Enzyme Inhib. Med. Chem. 32: 917-919.
Ambler, R.P. 1980. The structure of beta-lactamases. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 289: 321-331.
Bush, K., and G.A. Jacoby. 2010. Updated functional classification of b-lactamases. Antimicrob. Agents Chemother. 54: 969-976.
Ghafourian, S., N. Sadeghifard, S. Soheili, and Z. Sekawi. 2015. Extended spectrum beta-lactamases: definition, classification and epidemiology. Curr. Issues Mol. Biol. 17: 11-22.
Kliebe, C., B.A. Nies, J.F. Meyer, R.M. Tolxdorff-Neutzling, and B. Wiedemann. 1985. Evolution of plasmidcoded resistance to broad-spectrum cephalosporins. Antimicrob. Agents Chemother. 28: 302-307.
Paul, G.C., G. Gerbraud, A. Bure, A.M. Philippon, B. Pangon, and P. Courvalin. 1989. TEM-4, a new plasmidmediated b-lactamase that hydrolyzes broad-spectrum cephalosporins in a clinical isolate of Escherichia coli. Antimicrob. Agents Chemother. 33: 1958-1963.
Poirel, L., T. Naas, M. Guibert, E.B. Chaibi, R. Labia, and P. Nordmann. 1999. Molecular and biochemical characterization of VEB-1, a novel class A extended-spectrum b-lactamase encoded by an Escherichia coli integron gene. Antimicrob. Agents Chemother. 43: 573-581.
Poirel, L., I. Le Thomas., T. Naas, A. Karim, and P. Nordmann. 2000. Biochemical sequence analyses of GES-1, a novel class A extended-spectrum b-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae. Antimicrob. Agents Chemother. 44: 622-632.
Nordmann, P., and H. Mammeri. 2007. Extended-spectrum cephalosporinases: structure, detection and epidemiology. Future Microbiol. 2: 297-307.
Ewers, C., A. Bethe, T. Semmler, S. Guenther, and L.H. Wieler. 2012. Extended-spectrum b-lactamase-producing and AmpC-producing Escherichia coli from livestock and companion animals, and their putative impact on public health: A global perspective. Clin. Microbiol. Infect. 18: 646-655.
Yigit, H., A.M. Queenan, G.J. Anderson, et al. 2001. Novel carbapenem-hydrolyzing b-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 45: 1151-1161.
Poirel, L., G.F. Weldhagen, T. Naas, C. De Champs, M.G. Dove, and P. Nordmann. 2001. GES-2, a class A b-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem. Antimicrob. Agents Chemother. 45: 2598-2603.
Poirel, L., C. Héritier, V. Tolün, and P. Nordmann. 2004. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 48: 15-22.
Lauretti, L., M.L. Riccio, A. Mazzariol, et al. 1999. Cloning and characterization of bla(VIM), a new integronborne metallo-b-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob. Agents Chemother. 52: 3589-3596.
Nordmann, P. 2014. Carbapenemase-producing Enterobacteriaceae: overview of a major public health challenge. Med. Mal. Infect. 44: 51-56.
Madec, J.-Y., M. Haenni, P. Nordmann, et al. 2017. Extended-spectrum b-lactamase/AmpC-And carbapenemaseproducing Enterobacteriaceae in animals: A threat for humans? Clin. Microbiol. Infect. 23: 826-833.
Association Régionale de Santé et d'Identification Animales (ARSIA). 2018. Annual report (French version), 11-13. Available at https: //www.arsia.be/wp-content/uploads/ documents-Telechargeables/RA-2018-web.pdf, (accessed February 7, 2021).
Association Régionale de Santé et d'Identification Animales (ARSIA). 2019. Annual report (French version), 14. Available at https: //www.arsia.be/wp-content/uploads/ documents-Telechargeables/RA-2019-web.pdf, (accessed February 7, 2021).
Royal Decree of Belgium (French version). Moniteur Belge. 07-21-2016 updated 12-09-2020. Available at www .ejustice.just.fgov.be/eli/arrete/2016/07/21/2016024152/justel, (accessed February 7, 2021).
Cohen Stuart, J., C. Dierikx, N. Al Naiemi, et al. 2010. Rapid detection of TEM, SHV and CTX-M extendedspectrum b-lactamases in Enterobacteriaceae using ligation-mediated amplification with microarray analysis. J. Antimicrob. Chemother. 65: 1377-1381.
Zankari, E., H. Hasman, S. Cosentino, et al. 2012. Identification of acquired antimicrobial resistance genes. J. Antimicrob. Chemother. 67: 2640-2644.
Brettin, T., J.J. Davis, T. Disz, et al. 2015. RASTtk: A modular and extensible implementation of the RAST algorithm for building custom annotation pipelines and annotating batches of genomes. Sci. Rep. 5: 8365
Gonggrijp, M.A., I.M.G.A. Santman-Berends, A.E. Heuvelink, et al. 2016. Prevalence and risk factors for extended-spectrum b-lactamase-And AmpC-producing Escherichia coli in dairy farms. J. Dairy Sci. 99: 9001-9013.
Michael, G.B., H. Kaspar, A.K. Siqueira, et al. 2017. Extended-spectrum b-lactamase (ESBL)-producing Escherichia coli isolates collected from diseased foodproducing animals in the GERM-Vet monitoring program 2008-2014. Vet. Microbiol. 200: 142-150.
Ghosh, K.K., L.A.Lebert, S.A.McEwen, et al. 2019. Extendedspectrum b-lactamase and ampc b-lactamase-producing Escherichia coli isolates from chickens raised in small flocks in Ontario, Canada. Microb. Drug Resist. 25: 1250-1256.
Caroff, N., E. Espaze, D. Gautreau, H. Richet, and A. Reynaud. 2000. Analysis of the effects of -42 and -32 ampC promoter mutations in clinical isolates of Escherichia coli hyperproducing AmpC. J. Antimicrob. Chemother. 45: 783-788.
Mulvey, M.R., E. Bryce, D.A. Boyd, et al. 2005. Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals. Antimicrob. Agents Chemother. 49: 358-365.
Tracz, D.M., D.A. Boyd, R. Hizon, et al. 2007. AmpC gene expression in promoter mutants of cefoxitin-resistant Escherichia coli clinical isolates. FEMS Microbiol. Lett. 270: 265-271.
Hamed, R.B., J.R. Gomez-Castellanos, L. Henry, C. Ducho, M.A. McDonough, and C.J. Schofield. 2013. The enzymes of b-lactam biosynthesis. Nat. Prod. Rep. 30: 21-107.
Cantón, R., M.I. Morosini, O. Martin, S. De La Maza, and E.G.G. De La Pedrosa. 2008. IRT and CMT b-lactamases and inhibitor resistance. Clin.Microbiol. Infect. 14 Suppl 1: 53-62.
Cunningham, S.A., S. Vasoo, and R. Patel. 2016. Evaluation of the check-points check MDR CT103 and CT103 XL microarray kits by use of preparatory rapid cell lysis. J. Clin. Microbiol. 54: 1368-1371.
Powell, E.A., D. Haslam, and J.E. Mortensen. 2017. Performance of the check-points check-MDR CT103XL assay utilizing the CDC/FDA antimicrobial resistance isolate bank. Diagn. Microbiol. Infect. Dis. 88: 219-221.
